Valneva

Valneva FCF/Debt

The Free Cash Flow to Debt Ratio of Valneva (VLA.PA) as of Oct 20, 2026 is -31.54 %. In the previous year, Free Cash Flow to Debt Ratio was -38.68 % — a change of -18.45% (higher).

FCF/Debt

-31.54 %

YoY

-18.45%

Last updated:

Free Cash Flow to Debt Ratio of Valneva is 2025 -31.54 % . Free Cash Flow to Debt Ratio of Valneva was 2024 -38.68 % . It decreases by -18.45% higher compared to the previous year.

The Valneva FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
22.80 EUR
Jan 1, 2019
-6.28 EUR
Jan 1, 2020
112.15 EUR
Jan 1, 2021
-14.19 EUR
Jan 1, 2022
-180.25 EUR
Jan 1, 2023
-103.91 EUR
Jan 1, 2024
-38.68 EUR
Jan 1, 2025
-31.54 EUR
The Valneva FCF/Debt history
YEARFCF/DebtYoY
-31.54 %-18.45%
-38.68 %-62.78%
-103.91 %-42.35%
-180.25 %+1,170.22%
-14.19 %-112.65%
112.15 %-1,884.74%
-6.28 %-127.56%
22.80 %+85.46%
12.30 %+259.35%
3.42 %-112.97%
-26.39 %+3.32%
-25.54 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Free Cash Flow to Debt Ratio of Valneva is -31.54 % in 2025.

Free Cash Flow to Debt Ratio of Valneva changed from -38.68 % to -31.54 %, representing a -18.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Valneva since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Valneva with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Valneva

All Key Metrics — Valneva